Merck to Buy Harpoon Therapeutics for $680 Million
Wall Street Journal
Merck has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million.
https://www.wsj.com/articles/merck-to-buy-harpoon-therapeutics-for-680-million-a6cccc75